BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32733368)

  • 1. It's Time to Say Goodbye to the ESUS Construct.
    Fuentes B; Gutiérrez-Zúñiga R; Díez-Tejedor E
    Front Neurol; 2020; 11():653. PubMed ID: 32733368
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrent Stroke in a Young Patient with Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Quo Vadis?
    Feil K; Heinrich J; von Falkenhausen AS; Becker R; Küpper C; Müller K; Thunstedt DC; Sinner MF; Kääb S; Kellert L
    Case Rep Neurol; 2020; 12(1):45-49. PubMed ID: 32110227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent Foramen Ovale and Stroke-Current Status.
    Bang OY; Lee MJ; Ryoo S; Kim SJ; Kim JW
    J Stroke; 2015 Sep; 17(3):229-37. PubMed ID: 26437990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta-analysis?
    Chatterjee A; Hillegass WB
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1161-1162. PubMed ID: 30478879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Closure of Patent Foramen Ovale: Randomized Trial Update.
    Arfaras-Melainis A; Palaiodimos L; Mojadidi MK
    Interv Cardiol Clin; 2019 Oct; 8(4):341-356. PubMed ID: 31445719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale.
    Lee MJ; Park SJ; Yoon CH; Hwang JW; Ryoo S; Kim SJ; Kim GM; Chung CS; Lee KH; Bang OY
    J Stroke; 2016 Sep; 18(3):304-311. PubMed ID: 27733026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
    Diener HC; Bernstein R; Hart R
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment.
    Melkumova E; Thaler DE
    Interv Cardiol Clin; 2017 Oct; 6(4):487-493. PubMed ID: 28886840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining the evidence for PFO closure and novel oral anticoagulants for treatment of cryptogenic stroke.
    Khan R
    Expert Rev Cardiovasc Ther; 2020 Mar; 18(3):139-148. PubMed ID: 32085690
    [No Abstract]   [Full Text] [Related]  

  • 13. Cryptogenic stroke.
    Fonseca AC; Ferro JM
    Eur J Neurol; 2015 Apr; 22(4):618-23. PubMed ID: 25597418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplatzer patent foramen ovale occluder: safety and efficacy.
    Madhkour R; Wahl A; Praz F; Meier B
    Expert Rev Med Devices; 2019 Mar; 16(3):173-182. PubMed ID: 30741039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.
    Lee PH; Song JK; Kim JS; Heo R; Lee S; Kim DH; Song JM; Kang DH; Kwon SU; Kang DW; Lee D; Kwon HS; Yun SC; Sun BJ; Park JH; Lee JH; Jeong HS; Song HJ; Kim J; Park SJ
    J Am Coll Cardiol; 2018 May; 71(20):2335-2342. PubMed ID: 29544871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ESUS (embolic stroke of undetermined sources)].
    Kitagawa K
    Nihon Rinsho; 2016 Apr; 74(4):597-602. PubMed ID: 27333746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale and infarct volume in cryptogenic stroke.
    Jung JM; Lee JY; Kim HJ; Do Y; Kwon SU; Kim JS; Song JK; Kang DW
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1399-404. PubMed ID: 23747019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Role of 2-Phase Cardiac CT in Patients With Embolic Stroke of Undetermined Source.
    Yan S; Zhou Y; Han Q; Chen Y; Lou M
    Am J Med; 2020 Jun; 133(6):e290-e293. PubMed ID: 31870665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
    Eggers AE
    Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microembolic signal detection by transcranial Doppler: Old method with a new indication.
    Muengtaweepongsa S; Tantibundhit C
    World J Methodol; 2018 Nov; 8(3):40-43. PubMed ID: 30519538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.